Position | Bio | Architecture

Patients shouldn’t be deprived of survival knowledge.
I build systems that turn biology into earlier patient action.
So they won’t lose options.

Most patients lose survival options not because of the cancer alone, but because understanding comes too late.

I fix that by turning biology into clear, actionable understanding early.

I help people understand what is driving their cancer so they can act earlier, before options are lost.

This led me to identify the biological sequences that collapses into cholangiocarcinoma, and to build structured patient response systems that guide action before, during, and after diagnosis.

Steve Holmes
Co-Founder & CEO, Cholangio.org and Cholangiocarcinoma Foundation Australia
Late-stage IV cholangiocarcinoma survivor.

Cause → System → People → Survival

• The cure is in the cause.
• Systems organise the path.
• Discipline produces survival.

Cancer is not where the disease begins.
It is where the biological sequence has failed.

When that sequence is understood, response can be organised.
When response is organised, survival conditions improve.

That is how we improve survival. Now.

Cholangiocarcinoma is a time-poor cancer.

Patients are diagnosed into a fragmented system where understanding is delayed and decisions are made under pressure.

During that time, the disease continues to progress.
When time is lost, options are lost.

Biology → Physiology → Cognition
Parts → Engine → Driver

This work is built on three layers:

Biology: The Parts
Cells, ducts, and structures that make up the system.

Physiology: The Flow (Engine)
How those parts move, interact, and behave under pressure.

Cognition: The Driver
How patients, caregivers, and clinicians interpret and act within that system.

When these layers are understood together, the sequence becomes visible.
When the sequence is visible, the response can be organised.

The body runs on flow.

When that flow is disrupted, pressure builds, systems compensate, and damage begins.

The biliary system is the body’s primary metabolic engine.

It begins as fine ducts within the liver that collect bile produced by hepatocytes.

These ducts merge into the left and right hepatic ducts, forming the common hepatic duct.
The gallbladder connects via the cystic duct.
From there, bile travels through the common bile duct, passing through the head of the pancreas and into the duodenum.

There, pancreatic enzymes break fats into smaller components.
Bile then shapes them into micelles.

Micelles are biological delivery vehicles that transport nutrients into the body’s cellular network.

Without micelles, nutrient delivery fails.
Cellular resilience declines.
Health cannot be sustained.

My focus is not advocacy.
It is to improve survival for today’s patients. Today.

It begins with understanding the biological sequence that precedes cholangiocarcinoma.

Patients need orientation in the biology they are sitting inside.

The body is built to repair.
Cancer emerges when chronic injury outpaces the body’s ability to repair.

When repair fails:

• Cellular cooperation breaks down
• Programmed cell death fails
• Abnormal cells persist and displace healthy tissue

The governing sequence:

Acute injury → repair → recovery
Chronic injury → failed repair → loss of cooperation → cancer

Cancer is not a stealthy enemy.
It is a failure of biological sequence.

When that failure is understood, prevention becomes possible.

“Nature, to be commanded, must be obeyed.
Cholangiocarcinoma is no exception.”

This defines a structured patient response to cholangiocarcinoma.

The system begins at the point of disorientation.

A patient is diagnosed.
Information is fragmented.
Time is limited.
Pressure is high.

The first task is not action.
It is clarity.

Cognition must stabilise before effective action can occur.

Confusion is reduced.
False urgency is removed.
The governing biology is made visible.

Once clarity is established, sequence is enforced.

Cause is separated from consequence.
Biology is distinguished from ideology.
Decisions are ordered so each step follows what must be true before it.

From there, action becomes possible.

Patients, caregivers, and clinical teams can operate coherently.

Navigation improves.
Errors compound less rapidly.
Response becomes deliberate, not reactive.

This method is designed for real conditions.

It assumes:

• Incomplete information
• Time pressure
• Competing narratives

It does not rely on perfect data.

It relies on:

• Disciplined perception
• Structured decision-making
• Early escalation to experience

This is not a care model. It is a response system that functions before, during, and after biological collapse.

Positions

• Co-Founder & CEO, Cholangiocarcinoma Foundation Australia
• Advisory Member, Global Oncology Patient Advisory Council (All Cancers)
• Advisory Member, Global Cholangiocarcinoma Alliance
• Member, Australian Bridging Funding Coalition
• Member, Omico Patient Advisory Group (Comprehensive Genomic Profiling)

Contributions

• Author of the Doctrines of Cholangio, defining the biological and cognitive principles that underpin the system
• Architect of Cholangio.org OS – systemising biological and cognitive pathways into structured patient response
• Advisor to national and global cholangiocarcinoma pathways
• Advisor on strategic manuscripts and national reports
• Participant, Global Research Priorities, ICRN (Salt Lake City, 2025)
• Architect of patient-led OCRP operating systems and survival frameworks

Publications

• Co-Author, Controversies in the Management of Australian Biliary Tract Cancer and Clinical Guidelines (ANZ Journal of Surgery – submitted)
• Contributing Author, National Delphi Panel on Quality Indicators for Biliary Tract Cancer Care (Australia)
• Contributing Author, Australian Biliary Cancer Optimal Care Pathway
• Author, The Book of Cholangio (private distribution)
• Contributor to several national and international patient and caregiver publications

Steve Holmes is a late-stage IV cholangiocarcinoma survivor whose complete response emerged from a position where survival was not documented at the time.

This vantage is not retrospective. It is operational.

His judgement was formed under conditions where decisions were made in real time, margins were thin, and failure compounded quickly. This required disciplined perception, rapid sequencing, and the ability to distinguish signal from noise under pressure.

From this position, a patient-led system was developed to convert disorientation into coherent understanding.

When applied, patient response shifts from reactive to deliberate. Cognition stabilises early, allowing patients and caregivers to develop a coherent understanding of the biological system they are navigating.

Decisions are no longer driven by urgency alone, but by sequence and consequence. Navigation improves, errors compound less rapidly, and escalation occurs earlier and with greater purpose.

This creates a response that is coherent rather than fragmented, operating before, during, and after diagnosis without changing its governing logic.

This is not advocacy. It is not a care model, and it does not replace clinicians or clinical judgement.

It does not claim to cure cancer or promise outcomes. Instead, it operates alongside medical care by stabilising cognition, enforcing sequence, and improving decision quality under pressure.

This is not ideology. It does not compete with biology. It obeys it.

Cancer operates as a system, and response must operate as a separate layer.

Biology, physiology, and cognition define what exists.
Truth, context, clarity, and retention define how it is understood.
Perception, action, and will define how it is applied.

The output is an organised response that improves survival conditions.

Cancer is downstream of biological collapse. When cause is not understood, response fragments. When cause is understood, response can be sequenced.

Earlier understanding improves response. Improved response improves survival conditions. Prevention becomes possible.

Earlier action keeps options open.
Delay leads to loss of options.